L26/P-512 Clinical grade globulin-rich protein supplements improve human embryo implantation in vitro
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Seriola und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does supplementation of culture media with globulin-rich proteins enhance embryo quality and implantation potential compared to conventional human serum albumin (HSA)? Summary answer Globulin-rich proteins, Plasmanate and Embryo Transfer Supplement (ETS), enhanced blastocyst quality, increased OCT4-positive epiblast cell populations, and improved peri-implantation development in vitro. What is known already Human embryo culture media typically rely on human serum albumin (HAS) as their primary protein source, despite evidence that plasma-derived globulins play critical roles in embryo development, especially in cellular protection against oxidative stress, regulation of nutrient and metal ion transport, and modulation of implantation-related mechanisms. Nevertheless, the benefits of globulin-rich supplements in improving peri-implantation development remain relatively unexplored. Study design, size, duration Mouse and human embryos were analyzed using time-lapse culture, 2D and 3D in vitro implantation platforms. Human blastocyst quality and peri-implantation characteristics were compared between HSA-only and Plasmanate/ETS-enriched conditions. Participants/materials, setting, methods Mouse embryos and 157 human embryos were cultured in Global medium supplemented either with HSA or Plasmanate, followed by exposure to ETS during the implantation phase. Embryo development was evaluated via morphology scores, confocal imaging, pluripotency markers expression and matrix displacement analysis. Main results and the role of chance In mouse embryos, adding a globulin-enriched plasma protein fraction to culture media increased blastocyst formation (82% in albumin-only vs 95% in globulin-enriched, p < 0.05), shortened time to blastocyst, and improved hatching. When embryos were stratified by cohort performance, the supplement primarily rescued batches that fell below the mouse embryo assay cutoff, increasing blastulation from 66% (albumin-only) to 76% (globulin-enriched) (p < 0.05). In human embryos, globulin supplementation did not significantly improve blastulation (79 albumin-only vs 82% globulin-enriched; p > 0.05), but shifted outcomes toward higher morphological quality, increasing the proportion of top-grade blastocysts (4.6% albumin-only vs 15% globulin-rich, p < 0.05). To test implantation potential, embryos were also exposed to a globulin-enriched transfer/peri-implantation supplement and cultured in 2D and 3D collagen implantation platforms. Implantation/adhesion increased in the globulin-enriched group both in the 2D (69% in albumin-only vs 86% in globulin-enriched) and 3D model (64.6% to 74.5%). In the 3D model, embryos in the globulin-enriched condition showed also larger outgrowth area on day 10 (6.8 × 10^4 vs 3.7 × 104 µm², p = 0.0064) and 1.5-fold higher OCT4+ epiblast cell abundance. Limitations, reasons for caution The number of human embryos analyzed was limited, and implantation potential was evaluated from two in vitro models rather than by clinical outcomes. Wider implications of the findings Our results indicate that the use of globulin-enriched protein supplements enhance embryo quality via protective effect on the epiblast formation and promote implantation potential, suggesting a translational potential for improving ART success rates. Trial registration number No
Zitieren
APA
Seriola, A., Godeau, A., Aroca, E., Casals, M., Demestre, M., Parra, A., Ferrer-Vaquer, A., Veiga, A., Solé, M., Boada, M., & Ojosnegros, S. (2026). L26/P-512 Clinical grade globulin-rich protein supplements improve human embryo implantation in vitro. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.845
Vancouver
Seriola A, Godeau A, Aroca E, Casals M, Demestre M, Parra A, et al. L26/P-512 Clinical grade globulin-rich protein supplements improve human embryo implantation in vitro. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.845
BibTeX
@article{Seriola2026,
author = {Seriola, A. and Godeau, A. and Aroca, E. and Casals, M. and Demestre, M. and Parra, A. and Ferrer-Vaquer, A. and Veiga, A. and Solé, M. and Boada, M. and Ojosnegros, S.},
title = {L26/P-512 Clinical grade globulin-rich protein supplements improve human embryo implantation in vitro},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.845}
}
EUVIMED